About NRX-0305 NRX-0305 is a potent, selective, and orally bioavailable mutant-specific BRAF degrader that Nurix is exploring for use in oncology. Nurix has reported preclinical data demonstrating ...

Update on IND-enabling data for MP0712, a Radio-DARPin targeting DLL3 and labeled with 212Pb, co-developed with Orano Med; entering FIH studies ...

Apple today announced that WWDC 2025 starts June 9, and the logo for the conference hints at iOS 19's rumored new design.

A selection of bespoke coins honouring the life and career of Paul McCartney have sold for $753,600 (£582,808) at a special ...